Nike’s Phil and Penny Knight, $2B gift to Oregon Health & Science University’s Knight Cancer Institute
Portland, Oregon – August 14, 2025 – In what marks the largest single donation ever made to a U.S....
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Portland, Oregon – August 14, 2025 – In what marks the largest single donation ever made to a U.S....
Boston, MA – August 14, 2025 – Superluminal Medicines, a pioneering drug discovery company integrating artificial intelligence, machine learning,...
By NewsDesk — Aug. 7, 2025 (America/New York) Strand Therapeutics, a Boston‑based startup pioneering programmable messenger RNA (mRNA) therapies, closed a $153 million Series B...
NORTH CHICAGO, Ill., May 14, 2025 — AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration...
